|
1- octadecanoyl- 2- (5E,8E,11E,14E- eicosatetraenoyl)- sn- glycero- 3- phosphoethanolamine |
|
CHEBI:84837 |
|
1-octadecanoyl-2-(5E,8E,11E,14E-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine |
|
A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl substituents at positions 1 and 2 are specified as octadecanoyl (stearoyl) and (5E,8E,11E,14E)-eicosatetraenoyl respectively. |
|
![](images/goldenstar.gif) ![](images/goldenstar.gif)
This entity has been manually annotated by the ChEBI Team.
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C43H78NO8P/c1- 3- 5- 7- 9- 11- 13- 15- 17- 19- 20- 22- 24- 26- 28- 30- 32- 34- 36- 43(46) 52- 41(40- 51- 53(47,48) 50- 38- 37- 44) 39- 49- 42(45) 35- 33- 31- 29- 27- 25- 23- 21- 18- 16- 14- 12- 10- 8- 6- 4- 2/h11,13,17,19,22,24,28,30,41H,3- 10,12,14- 16,18,20- 21,23,25- 27,29,31- 40,44H2,1- 2H3,(H,47,48) /b13- 11+,19- 17+,24- 22+,30- 28+/t41- /m1/s1 |
ANRKEHNWXKCXDB-GKGUFKCQSA-N |
CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCCN)OC(=O)CCC\C=C\C\C=C\C\C=C\C\C=C\CCCCC |
|
ceramide allergen
Any ceramide which causes the onset of an allergic reaction.
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
|
|
View more via ChEBI Ontology
Outgoing
|
1- octadecanoyl- 2- (5E,8E,11E,14E- eicosatetraenoyl)- sn- glycero- 3- phosphoethanolamine
(CHEBI:84837)
has functional parent
octadecanoic acid
(CHEBI:28842)
1- octadecanoyl- 2- (5E,8E,11E,14E- eicosatetraenoyl)- sn- glycero- 3- phosphoethanolamine
(CHEBI:84837)
has role
ceramide allergen
(CHEBI:143252)
1- octadecanoyl- 2- (5E,8E,11E,14E- eicosatetraenoyl)- sn- glycero- 3- phosphoethanolamine
(CHEBI:84837)
has role
mouse metabolite
(CHEBI:75771)
1- octadecanoyl- 2- (5E,8E,11E,14E- eicosatetraenoyl)- sn- glycero- 3- phosphoethanolamine
(CHEBI:84837)
is a
1,2-diacyl-sn-glycero-3-phosphoethanolamine
(CHEBI:64674)
|
|
(21R)- 27- amino- 24- hydroxy- 24- oxido- 18- oxo- 19,23,25- trioxa- 24λ5- phosphaheptacosan- 21- yl (5E,8E,11E,14E)- icosa- 5,8,11,14- tetraenoate
|
PE(18:0/20:4(5E,8E,11E,14E))
|
LIPID MAPS
|
PE(18:0/20:4)
|
LIPID MAPS
|
|